About Arrestin domain-containing protein 3
Arrestin domain-containing protein 3 (ARRDC3) is a protein
from Homo sapiens identified by UniProt accession
Q96B67, 414 residues long.
MolForge cross-references it against 0 known binders and
111 disease associations.
Target properties
| Protein name | Arrestin domain-containing protein 3 |
| UniProt accession | Q96B67 |
| Gene | ARRDC3 |
| Organism | Homo sapiens |
| Length | 414 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (111)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.42
- mean corpuscular hemoglobin concentration · score 0.36
- breast carcinoma · score 0.36
- neurodegenerative disease · score 0.36
- platelet component distribution width · score 0.35
- hippocampal tail volume · score 0.30
- mathematical ability · score 0.29
- mean corpuscular hemoglobin · score 0.29
- creatinine measurement · score 0.28
- neuroimaging measurement · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96B67-F1 | alphafold | PREDICTED | 82.20 | — |
Amino-acid sequence (414 residues)
MVLGKVKSLT ISFDCLNDSN VPVYSSGDTV SGRVNLEVTG EIRVKSLKIH ARGHAKVRWT ESRNAGSNTA YTQNYTEEVE YFNHKDILIG HERDDDNSEE GFHTIHSGRH EYAFSFELPQ TPLATSFEGR HGSVRYWVKA ELHRPWLLPV KLKKEFTVFE HIDINTPSLL SPQAGTKEKT LCCWFCTSGP ISLSAKIERK GYTPGESIQI FAEIENCSSR MVVPKAAIYQ TQAFYAKGKM KEVKQLVANL RGESLSSGKT ETWNGKLLKI PPVSPSILDC SIIRVEYSLM VYVDIPGAMD LFLNLPLVIG TIPLHPFGSR TSSVSSQCSM NMNWLSLSLP ERPEAPPSYA EVVTEEQRRN NLAPVSACDD FERALQGPLF AYIQEFRFLP PPLYSEIDPN PDQSADDRPS CPSR
Explore Arrestin domain-containing protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets